A share price of Essa Pharma Inc [EPIX] is currently trading at $1.63, down -1.21%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The EPIX shares have gain 10.88% over the last week, with a monthly amount glided 1.87%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Essa Pharma Inc [NASDAQ: EPIX] stock has seen the most recent analyst activity on November 04, 2024, when Piper Sandler downgraded its rating to a Neutral and also revised its price target to $2 from $15. Previously, Oppenheimer downgraded its rating to Perform on November 04, 2024. On November 04, 2024, downgrade downgraded it’s rating to Hold. Piper Sandler initiated its recommendation with a Overweight and recommended $50 as its price target on March 04, 2021. H.C. Wainwright reiterated a Buy rating for this stock on January 11, 2021, and upped its price target to $17. In a note dated November 02, 2020, Jefferies initiated an Buy rating and provided a target price of $17 on this stock.
Essa Pharma Inc experienced fluctuations in its stock price throughout the past year between $1.40 and $7.99. Currently, Wall Street analysts expect the stock to reach $2 within the next 12 months. Essa Pharma Inc [NASDAQ: EPIX] shares were valued at $1.63 at the most recent close of the market. An investor can expect a potential return of 22.7% based on the average EPIX price forecast.
Analyzing the EPIX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.25, Equity is -0.24 and Total Capital is -0.26. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.5950 points at the first support level, and at 1.5599 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.6851, and for the 2nd resistance point, it is at 1.7401.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Essa Pharma Inc [NASDAQ:EPIX] is 33.12. In addition, the Quick Ratio stands at 33.12 and the Cash Ratio stands at 25.31.
Transactions by insiders
Recent insider trading involved BIOTECH GROWTH N V, 10% Owner, that happened on Nov 01 ’24 when 7.88 million shares were sold. Chief Operating Officer, Virsik Peter completed a deal on Oct 07 ’24 to sell 694.0 shares. Meanwhile, Chief Operating Officer Virsik Peter sold 694.0 shares on Sep 09 ’24.
